Differences

This shows you the differences between two versions of the page.

--- articles:re-thinking_capa [2022/03/06 21:11] – [Why should you "re-think" CAPA?] rrandall
+++ articles:re-thinking_capa [2023/03/16 17:51] (current) – [How do we address this conflict?] rrandall
@@ Line 32: / Line 32: @@
 Rather than repeat an earlier article, read: [[articles:whac-a-mole|Corrective Action "Whac-A-Mole"]].
-===== How do we address this conflict? =====
+==== Institutionalized Delusion ====
+Amazingly, ISO 13485:2016, "Medical devices — Quality management systems — Requirements for regulatory purposes” was re-affirmed in 2020 (with no changes). This standard retains the CAPA concept (addressed in ISO 13485, sec. 8.5) under the misguided belief that it will one day achieve the mythical "Zero Defects"... completely oblivious that it is perpetuating the inefficiency of [[articles:whac-a-mole|Corrective Action "Whac-A-Mole"]].
+And this delusion continues to be reinforced by the US FDA (Food & Drug Administration) promoting the CAPA concept:
+https://www.fda.gov/corrective-and-preventive-actions-capa
+Sadly, the medical device & pharmaceutical industries continue to doggedly embrace the ignorance promoted by the cult of "Zero Defects".